Danaher DHR
NYSE DHR
$212.54 +4.18 (+2.01%)
As of: Sep 17, 2026 · 3:59 PM EDT

Danaher (DHR) Net Income Growth (1y) (2010 - 2026)

Analysis

Danaher (DHR) Net Income Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 8.66%
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 56.76%
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 7.74%
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -11.91%
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -3.94%
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 179.36%
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 16.87%
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -66.31%
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -151.92%
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -816.48%
Historic Data

Historic Data

Download Data
DateValue
Jun 26, 2026 56.76%
Mar 27, 2026 7.86%
Dec 31, 2025 8.93%
Sep 26, 2025 11.00%
Jun 27, 2025 -38.81%
Mar 28, 2025 -12.32%
Dec 31, 2024 0.65%
Sep 27, 2024 -27.55%
Jun 28, 2024 -17.99%
Mar 29, 2024 -24.97%
Dec 31, 2023 -31.32%
Sep 29, 2023 -37.31%
Jun 30, 2023 -42.49%
Mar 31, 2023 -24.24%
Dec 31, 2022 -12.14%
Sep 30, 2022 55.53%
Jul 1, 2022 7.73%
Apr 1, 2022 12.46%
Dec 31, 2021 44.08%
Oct 1, 2021 31.14%